Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/21/08 → 01/25/11 |
Funding
- Parexel International LLC: $3,000.00
Johnson & Johnson: A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose....
- Rashba, Eric (PI)
- Almasry, Ibrahim (CoPI)
- Barbera, Saverio (CoPI)
Project: Research